97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03565939
(ClinicalTrials.gov)
May 4, 201822/5/2018Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)Ulcerative Colitis Chronic ModerateBiological: Trichuris suis ova;Biological: PlaceboParaTech A/SNULLCompleted18 Years75 YearsAll119Phase 2Denmark
2EUCTR2017-004772-65-DK
(EUCTR)
05/02/201804/12/2017Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova (TSO)Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova (TSO) - PROCTO Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Code: TSO
INN or Proposed INN: TSO
Other descriptive name: SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML
ParaTech A/SNULLNot RecruitingFemale: yes
Male: yes
120Phase 2Denmark
3NCT01953354
(ClinicalTrials.gov)
November 201324/9/2013Trichuris Suis Ova Treatment in Left-sided Ulcerative ColitisA Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and MicrobiotaColitis, UlcerativeBiological: Trichuris suis ova (TSO);Biological: PlaceboNational Institute of Allergy and Infectious Diseases (NIAID)Coronado Biosciences, Inc.;Autoimmunity Centers of ExcellenceTerminated18 Years70 YearsAll16Phase 2United States